Search clinical trials for: Adrenergic beta-2 Receptor Agonists

Total 9910 results

Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma

Asthma

United States
University of Nevada, Las Vegas

Terminated

Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity

Asthma in Children | Obesity, Childhood | Exercise Induced Bronchospasm

United States
Chiesi Farmaceutici S.p.A.

Completed

A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients. (ADONE)

Asthma

United Kingdom, Denmark
AstraZeneca

Completed

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Asthma

United States
University of Dundee

Completed

Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol (NAI009)

Asthma

United Kingdom
GlaxoSmithKline

Completed

Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Argentina, Spain, Chile, Germany, Korea, Republic of, Bulgaria, Brazil, Slovakia
University of Aarhus

Completed

The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.

Ventricular Septal Defect

Denmark
Chiesi Farmaceutici S.p.A.

Completed

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

Asthma

Germany
University of Monastir

Completed

β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

Acute Exacerbation of Chronic Obstructive Airways Disease

Tunisia
University Medical Center of Southern Nevada

Completed

The Various Effects of Gaseous Albuterol on Serum Lactate

Asthma

United States
Chiesi Farmaceutici S.p.A.

Completed

Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients

Asthma

United Kingdom
Verona Pharma plc

Completed

Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients

Asthma

Sweden, United Kingdom
Central Hospital, Nancy, France

Completed

Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis (SALBUTAMOL)

Asthma

France
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes

Asthma | Children

Brazil
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Different Doses of Indacaterol

Asthma

United States
Hamilton Health Sciences Corporation
Sunovion

Completed

Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma

Asthma
Children's Hospital Medical Center, Cincinnati

Terminated

Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation

Status Asthmaticus

United States
Otsuka Pharmaceutical, Inc., Philippines
Otsuka Pharmaceutical Co., Ltd.

Terminated

Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients

Pulmonary Disease, Chronic Obstructive

Philippines
Bispebjerg Hospital
Hormone Laboratory, Aker University Hospital, Oslo, Norway

Unknown

Concentrations of Formoterol in Blood and Urine

Asthma

Denmark
Shachi Tyagi
National Institute on Aging (NIA)

Recruiting

Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women (SLAB)

Nocturia | Urgency Urinary Incontinence

United States
Genuine Research Center, Egypt
Multi-Apex Pharma

Completed

Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus Myrbetriq 25 mg Extended Release Tablets (Marketed by Astellas Pharma US, Inc, Product of Japan)

Healthy

Egypt
University of Avignon

Completed

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

Diabetes-related Complications

France
Hvidovre University Hospital

Completed

DOCICAR: Cardiac Dysfunction in Cirrhosis

Cirrhosis | Cirrhotic Cardiomyopathy

Denmark
Aristotle University Of Thessaloniki

Completed

Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke

Stroke, Ischemic

Greece
University of Colorado, Denver

Completed

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Type 1 Diabetes

United States
Seoul National University Hospital

Unknown

Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma

Normal Tension Glaucoma

Korea, Republic of
Centro Cardiologico Monzino

Completed

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure (CARNEBI)

Chronic Heart Failure

Italy
Trinity Hypertension & Metabolic Research Institute
Allergan Sales, LLC

Completed

Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH (BVreduce)

Blood Pressure | Hypertrophy, Left Ventricular | Hypertension Complicated

United States
IRCCS Policlinico S. Matteo
Merck Sharp & Dohme LLC; Menarini Group

Unknown

Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients (MaNeLo)

Marfan Syndrome

Italy
VA Office of Research and Development

Terminated

Albuterol to Improve Respiratory Strength in SCI

Spinal Cord Injury | Respiratory Muscle Weakness

United States
University of California, San Francisco
Flight Attendant Medical Research Institute

Active, not recruiting

Secondhand Smoke Respiratory Health Study

Hyperinflation | Tobacco | Obstructive Lung Disease | Secondhand Smoke | Air Trapping | Airflow Limitation

United States
ARS Pharmaceuticals, Inc.

Active, not recruiting

Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Asthma

United States
Boehringer Ingelheim

Completed

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

Pulmonary Disease, Chronic Obstructive

United Kingdom, Turkey, United States, Greece, Portugal, Finland, Italy, Sweden
Theravance Biopharma

Completed

Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19

COVID-19

United States
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Asthma

United Kingdom, Germany
Morten Hostrup, PhD

Unknown

Beta2-adrenergic Agonism and Muscle Remodelling

Physical Activity | Hypertrophy | Physiologic Hypertrophy

Denmark
Children's Hospital of Philadelphia

Completed

Aerosolized Albuterol Use in Severe BPD

Severe Bronchopulmonary Dysplasia

United States
GlaxoSmithKline

Completed

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

Pulmonary Disease, Chronic Obstructive

Germany, Spain, United States, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
ADIR Association

Completed

Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients (CLAD)

Chronic Lung Allograft Dysfunction | Bronchiolitis Obliterans Syndrome | Transplantation, Heart-Lung

United Kingdom
Amphastar Pharmaceuticals, Inc.

Completed

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Bronchospasm

United States
Dey

Completed

Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)

COPD

United States
AstraZeneca

Completed

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States, Australia, Canada, New Zealand
AstraZeneca

Completed

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
University of New Mexico

Withdrawn

Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) (EIB)

Exercise-induced Bronchospasm

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD

Spain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
Pearl Therapeutics, Inc.

Withdrawn

Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

COPD

United States
Boehringer Ingelheim

Completed

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Asthma

United States
IRCCS Azienda Ospedaliera Universitaria San Martino...

Completed

Respiratory Impedance and Obliterative Bronchiolitis (FOT-BOS)

Hematopoietic Stem Cell Transplantation | Obliterative Bronchiolitis

Italy
University of Cape Town
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Rapid Diagnosis of Pulmonary Tuberculosis

Tuberculosis

South Africa
Sunovion

Completed

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Exercise-induced Bronchospasm

United States

3

Subscribe